Bigbear Pharmaceutical·Medication Guide

• Is Capmatinib Covered by Insurance? Navigating Medicare and Patient Assistance Programs

  Carmatinib (Tabrecta) is a highly selective MET receptor tyrosine kinase inhibitor that specifically inhibits the phosphorylation of MET receptors and···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 105

• Ixazomib Generic Availability 2026: Will Prices Drop Soon? Latest Updates & Cost Outlook

  Ixazomib, a novel targeted therapy drug, inhibits the activity of the proteasome, blocking the growth and proliferation of tumor cells, providing an i···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 120

• How to Save Money on Ixazomib: Patient Assistance Programs & Prescription Discounts in 2026

  Ixazomib is an oral proteasome inhibitor primarily used in the clinical treatment of multiple myeloma. As a novel targeted therapy, it blocks the grow···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 131

• FDA Approves Lenvima (lenvatinib) for the Treatment of Patients with Advanced Renal Cell Carcinoma

  Approval AnnouncementWOODCLIFF LAKE, N.J., May 13, 2016 /PRNewswire/ -- Eisai Inc. announced that the U.S. Food and Drug Administration (FDA) has appr···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 121

• FDA Approves Lenvima (lenvatinib) for First-line Treatment of Unresectable Hepatocellular Carcinoma

  Approval AnnouncementWoodcliff Lake, NJ and Kenilworth, NJ, Aug. 16, 2018 – Eisai Inc. and Merck (NYSE: MRK, known as MSD outside the U.S. and Canada)···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 111

• FDA Approves Keytruda (pembrolizumab) Plus Lenvima (lenvatinib) Combination for Certain Advanced End

  Approval AnnouncementKENILWORTH, N.J., & WOODCLIFF LAKE, N.J.-- September 17, 2019 -- Merck (NYSE: MRK, known as MSD outside the U.S. and Canada) ···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 109

• FDA Approves Keytruda (pembrolizumab) Plus Lenvima (lenvatinib) Combination for First-Line Treatment

  Approval OverviewAugust 11, 2021 — Merck (NYSE: MRK, known as MSD outside the U.S. and Canada) and Eisai announced the U.S. Food and Drug Administrati···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 115

• Where to Buy Letermovir Reliably

  Indications of LetermovirLetermovir is a prescription medication used to help prevent cytomegalovirus (CMV) infection and disease in adults at high ri···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 114

• What other drugs will affect avatrombopag?

  Certain medications may interact with avatrombopag, including prescription drugs, over-the-counter medicines, vitamins, and herbal products. Inform yo···【Read More】

  Update: 2026-03-12Source: Haiou HealthViews: 120

• What to avoid

  Follow your doctor’s guidance regarding any restrictions on food, beverages, or activities.【Read More】

  Update: 2026-03-12Source: Haiou HealthViews: 125

• What happens if I overdose of Avatrombopag?

  If you take more avatrombopag tablets or sprinkle than prescribed, contact your healthcare provider or call the Poison Help Line immediately, or go to···【Read More】

  Update: 2026-03-12Source: Haiou HealthViews: 114

• What happens if I miss a dose of Avatrombopag?

  For chronic immune thrombocytopenia: If you miss a dose, take it as soon as you remember. Then, take your next dose at the usual time and continue wit···【Read More】

  Update: 2026-03-12Source: Haiou HealthViews: 118

• Ivosidenib Price Comparison: Brand vs. Generic vs. International Options

  Evonib, a highly selective IDH1 gene mutation inhibitor, blocks abnormal metabolic processes in tumor cells through targeted action. It is primarily u···【Read More】

  Update: 2026-03-12Source: Haiou HealthViews: 131

• Ivosidenib (Tibsovo) Cost 2026: Patient Assistance & Generic Options

  Evonib is an IDH1-targeting inhibitor. This drug works by precisely targeting the mutated IDH1 protein, blocking abnormal metabolic pathways in tumor ···【Read More】

  Update: 2026-03-12Source: Haiou HealthViews: 113

• Is Enasidenib Covered by Insurance? Exploring Out-of-Pocket Costs for AML Patients

  Encilidipine, also known as IDHIFA or encilidipine mesylate, is a drug used to treat adult patients with relapsed or refractory acute myeloid leukemia···【Read More】

  Update: 2026-03-12Source: Haiou HealthViews: 104